ABOUT US

sqn-full-service-header

Based on quality, trust and flexibility we work as a natural extension of your own team

 

SQN Clinical – the biometrics partner of choice for clinical development professionals.

sqn-team-about-header

Our focus is on meeting your objectives

SQN has a well-earned international reputation as a specialist data management company who can be trusted to meet the biometrics needs of your projects, while working seamlessly with your team and chosen partners. Your focus is likely to be pharmaceutical, biotechnology or medical device development; ours is to help you get your product to market as quickly and efficiently as possible – at reasonable cost with the highest confidence that it will meet regulatory needs.

For over 20 years, we’ve been taking the stress and risk out of planning, managing, analysing and reporting clinical trials. We are the preferred, trusted partner of choice for both local and internationally-based companies; we always keep our promises. The high percentage of repeat business we enjoy is testament to every member of our team going the extra mile, providing a quality service within agreed timelines and budgets, ensuring complete satisfaction.

 

Veristat, a perfect fit

Veristat was founded on strong Biometrics expertise and has grown to become a  global specialty CRO that brings a range of experience in clinical trial planning and execution. Our focus on novel drug development has led to success when handling the unknowns that arise across complicated therapeutic areas, such as rare/ultra-rare diseaseadvanced therapiesoncology, and infectious disease trials. We apply this knowledge base every day to solve any clinical program's challenges, from the simplest to the most complex. Our team has prepared nearly 100 marketing applications for approval with global regulatory authorities in the last 10 years and remains a trusted resource in bringing the right people, processes, and technology together to glean the most value from your clinical data and move your trials successfully forward.